HIV lipoatrophy

HIV lipoatrophy

A subset of lipodystrophy that is liable to complicate prolonged multidrug antiretroviral therapy for HIV infection. There is peripheral breakdown of subcutaneous fat and central fat accumulation associated with type 2 diabetes. The effect is thought to be due to the use of nucleoside-analogue reverse-transcriptase inhibitors and HIV-PROTEASE INHIBITORS.